Breakthrough T1D shares the latest research at ISPAD
At the 2024 International Society for Pediatric and Adolescent Diabetes (ISPAD) Conference in Lisbon, Portugal, the world’s leading diabetes researchers,…
Breakthrough T1D and the Nobel Prizes: Connected!
It’s early October, which means the Nobel Prizes are being awarded in several categories. These prestigious awards recognize outstanding contributions…
New ICD-10 Codes Will Help the T1D Community
On October 1st, the T1D community got a big win: the Centers for Medicare and Medicaid Servies (CMS) introduced a…
ADA Takeaways: Day 2
At the ADA Scientific Sessions, scientists will present the latest T1D research, all with the goal of improving lives for…
Breakthrough T1D Spearheads the Formation of Monitoring Guidelines
We spearheaded an effort to develop the first internationally agreed-upon guidance for anyone who tests positive for T1D autoantibodies.
Powering research breakthroughs
We invest in the most promising research to turn ideas into life-changing therapies and lead the way to cures.
Multiple Benefits of Screening For Beta Cell Autoimmunity in Children
Learn more about Breakthrough T1D’s prevention research and the benefits of early detection for type 1 diabetes (T1D).
